Anondita Medicare Limited, a leading manufacturer of male condoms under the flagship brand “COBRA”, has come up with its public issue that has gained massive investor traction. The company operates with an installed production capacity of nearly 562 million condoms per annum as certified by Chartered Engineer JP Sood on June 04, 2025.

The Initial Public Offering (IPO) of Anondita Medicare is a Book Built Issue amounting to ₹69.50 Crores, consisting entirely of a Fresh Issue of 47.93 lakh equity shares. The IPO opened for subscription on August 22, 2025, and closed on August 26, 2025.

The price band for the IPO was fixed between ₹137 and ₹145 per equity share. At the upper end of the price band, the company’s market capitalization is expected to touch ₹262.26 Crores. The lot size has been set at 1,000 shares, with retail investors required to invest in a minimum of 2 lots (2,000 shares), amounting to ₹2,90,000.

The issue is managed by Narnolia Financial Services Limited as the Book Running Lead Manager, while Maashitla Securities Private Limited acts as the Registrar. The Market Maker for the issue is Mansi Share Stock Broking Private Limited.

IPO Subscription and Investor Response

The IPO witnessed an overwhelming response, with a subscription of 114.77 times by the final day (as of 12:30 PM on August 26, 2025). This reflects strong investor confidence in the company’s growth potential and product demand.

Grey Market Premium (GMP)

The Grey Market Premium (GMP) for Anondita Medicare IPO is currently quoted at ₹25, indicating an expected listing price of ₹170 against the upper band of ₹145. However, it is important to note that GMP is unofficial and purely indicative, as no actual trades happen on this platform.

Anchor Investors

Ahead of the IPO opening, the company successfully raised ₹19.60 Crores from Anchor Investors by allotting 13,52,000 equity shares at ₹145 per share in consultation with the lead managers.

Allotment and Listing Timeline

The IPO allotment date is scheduled for August 28, 2025 (Thursday). Investors can check their allotment status online through the registrar’s portal using their application number, PAN, or DP Client ID. The shares are expected to be listed on the NSE SME platform with a tentative listing date of September 1, 2025 (Monday).

Utilisation of IPO Proceeds

The net proceeds from the IPO will be directed towards key growth areas:

1. ₹600 lakh for purchase of new equipment and machinery.

2. ₹3,500 lakh for working capital requirements.

3. Remaining funds for acquisitions and general corporate purposes.

Day-wise GMP Trend

On August 20, 2025, the IPO price stood at ₹145, with an expected listing price of ₹170, resulting in a GMP of ₹25 (17.24%).

Conclusion

The overwhelming subscription numbers of the Anondita Medicare IPO underline investor faith in the company’s business model, brand recall through “COBRA”, and the rising demand for contraceptive healthcare products in India and global markets. With a strong GMP trend, robust anchor backing, and clear utilisation of proceeds, the IPO is set to make a notable debut on the NSE SME platform.

The Upcoming IPOs in this week and coming weeks are Amanta Healthcare, Rachit Paints, Abril Paper Tech, Sneha Organics, Sugs Lloyd, .

The Current active IPO are Anlon Healthcare, NIS Management, Sattva Engineering Construction, Globtier Infotech, Current Infraprojects, Vikran Engineering, Shivashrit Foods, Anondita Medicare, Classic Electrodes (India).

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.